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the clinical success of AF ablation depends on persistent block-
ing of electrical conduction across the ablation lines. With
bipolar radiofrequency (RF) clamps, the PV cuff is physically
clamped and burned repeatedly in order to achieve ‘acute’ con-
duction block. A question for further reﬂection is: are we achiev-
ing block at that moment because of local tissue trauma and
inﬂammation resulting from simultaneous crushing and burning
of the PV cuff and is that block durable? Indeed, Benussi et al. [2]
have shown previously that despite achieving block acutely with
bipolar RF clamps, the veins often recover their ability to
conduct (at 3 weeks in 15% of ablated patients).
It has been hypothesized that HIFU lesions may take time to
scar in and mature. The mode of cell death for this energy
source may differ from that of RF and thus may not always be in-
stantaneous. Villamizar et al. [3] have demonstrated that HIFU
ablation achieved 100% transmurality.
In our experience of using HIFU in 70 cases, we have observed
thought-provoking clinical results. The freedom from recurrence
of AF after ablation was 82% at 1 month, 90% at 1 year and
100% at 3 years in patients presenting with preoperative parox-
ysmal AF and undergoing concomitant open heart cardiac
surgery with creation of only a box lesion and no additional ab-
lation lines. Those patients were also free from anti-arrhythmic
drugs at the time of follow-up. Those impressive results,
however, were not observed in patients presenting preoperative-
ly with permanent AF, showing a freedom from recurrence of AF
of 42% at 1 month, 54% at 1 year and 62% at 3 years.
Our experience suggests that in order to achieve good clinical
results using the HIFU ablation system it is important to use it in
the right patients. In our experience, those patients presented
with paroxysmal AF with normal or mildly dilated left atria (area
<30 cm2; volume <68 ml). We consider a simple box lesion sufﬁ-
cient to achieve a good postoperative clinical result. In patients
with permanent AF, a more complex approach should be
applied to treat an evolved histopathological condition of the
atria.
We believe that the HIFU epicardial ablation system is a high-
performing treatment modality creating transmural lesions in the
left atrium and yielding good clinical results. Perhaps it is time to
revisit the theory of acute conduction block!
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Colli et al., commenting on the electrophysiological efﬁcacy of
high-intensity focused ultrasound (HIFU), propose a revision of
the acute conduction block theory, as a means to conﬁrm effect-
ive pulmonary veins (PVs) isolation [1, 2].
Although this proposal could be original, albeit not supported
by evidence, it is in contrast with the general agreement sur-
rounding the end-points for atrial ﬁbrillation (AF) ablation.
In the areas of consensus on ablation techniques identiﬁed by
the task force in the recently published Consensus Statement on
AF catheter and surgical ablation [3], complete electrical isolation
of all PVs should be the goal in every ablation strategy targeting
the PVs and/or the PV antrum. So, if the PVs are targeted,
electrical isolation should be the goal, and its achievement
requires, at a minimum, the assessment and demonstration of
conduction block across the PVs lesion. Likewise for surgical PVs,
isolation entrance and/or exit block should be validated.
Since such acute validation can overestimate success, the
Consensus also suggests an extra period of 20 min following PV
isolation, to identify and treat PVs reconduction initially masked
by the inﬂammation process, which gives an apparent acute
conduction block.
The evidence supporting the correlation between complete
electrical isolation and clinical efﬁcacy of ablation is clear-cut,
since the major predictor of arrhythmia recurrence after catheter
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ablations is the absence of PVs isolation, indicating restored PV
conduction or ineffective PV disconnection. Such a direct cause–
effect relationship between PV isolation and cure supports the
central role of durable transmurality of the ablations in AF treat-
ment [4].
Despite the penetration properties of HIFU ablations being ex-
tensively studied at histology, the results are reported in the very
acute context and the conduction block has normally not been
evaluated. Hence, inferences between histological transmurality
and electrophysiological block in the long-term remain
undocumented.
Colli and Romero-Ferrer state that in their surgical experience,
the freedom from recurrence after HIFU ablation (unpublished
data) improves with time, suggesting a progressive increase of
the ablation efﬁcacy. They speculate that these results might be
related to a putative alternative modality of delayed cell death
caused by HIFU.
However, a comprehensive study conducted on eight dogs
undergoing PV HIFU ablations suggests that the mechanism of
permanent injury is irreversible cell death, through coagulative
necrosis due to rapid hyperthermal toxicity occurring within
the focused zone [5]. Even if different forms of necrotic cell
death can be distinguished, based on their initiating mechan-
isms, i.e. necrosis, necroptosis and secondary necrosis,
the downstream cascade of events that occurs thereafter
takes place in an invariant fashion, during the following few
hours [6].
In conclusion, to the best of the authors’ knowledge, ablation
lesions can only get worse with time. Based on current evidence,
there is no described biological mechanism that may explain a
delayed myocardial cell death where the triggering event occurs
during the ablation and the outcome cannot be detected after 3
weeks, as performed in our study.
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We read with great interest the comprehensive review article
of Funder [1] on the clinical and experimental data surround-
ing the use of stentless aortic bioprostheses and fully agree
with his conclusions. There is no doubt that they are ideal
substitutes in patients with small aortic roots to prevent
patient–prosthesis mismatch. In this context, they should be
implanted in a ‘full-root’ type of technique to minimize
the postoperative aortic regurgitation that may occur due to
distortion of the prosthesis [2] and to facilitate both pros-
thesis over-sizing and the optimization of haemodynamic
results [3].
However, we were surprised that Funder did not comment on
the value of stentless valves in the context of aortic endocarditis,
particularly in patients with root abscesses and prosthetic valve
endocarditis. Homografts have been the gold standard for valve
and root replacement in aortic endocarditis for a long time. L
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